Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Hanta Virus Market Size study, by Symptoms (Fever, Body Aches, Hemolytic Anaemia, Thrombocytopenia, Abdominal Pain, Hantavirus Pulmonary Syndrome (HPS), Haemorrhagic Fever with Renal Syndrome (HFRS)) by Mode of Transmission (Urine, Faces, Salvia, Rodent Bite, Airborne Particles Containing These Excretions), by Drug Type (Branded, Generic), by Route of Administration (Oral, Injectable, Others), by End-Users (Hospitals, Academic Research Institutes, Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) and Regional Forecasts 2021-2027

  • BIZ4899587
  • 200 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Hanta Virus Market is valued approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2021-2027. Hanta Virus is a disease that is caused by rodent causes febrile haemorrhagic diseases which can often cause kidney damage or failure. The virus can spread when virus contain rodent urine, droppings, or saliva are stirred in the air. The increasing cases of hantavirus is likely to increase the market growth for the market in the forecasted period. For Instance: as per the Gavi the Vaccine Alliance, in 2021, reported that there are approximately 200,00 new cases each year globally. Also, rising awareness about the Hanta virus which leads to the adoption & demand for Hanta Virus is likely to increase the market growth during the forecast period. On the other hand, there is no specialized medication or vaccine for Hanta virus market which is the main challenge associated with the market.

The key regions considered for the global Hanta Virus market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America accounts for the largest market share owing to the proper investment in surveillance for hanta virus cases. Whereas, Asia-Pacific is anticipated to exhibit highest growth rate for the forecast period 2021-2027. Factors such as increasing government investment in healthcare sector would create lucrative growth prospects for the Hanta Virus market across Asia-Pacific region.

Major market player included in this report are:

PharmJet

Taj Pharmaceutical Limited.

Lupin

Merck Sharp & Dohme Corp.

Genentech, Inc.

Aurobindo Pharma

Zydus Pharmaceuticals, Inc.

F. Hoffmann-La Roche Ltd.

Kadmon Pharmaceuticals

Schering Corp

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Symptoms:

Fever

Body Aches

Hemolytic Anaemia

Thrombocytopenia

Abdominal Pain

Hantavirus Pulmonary Syndrome (HPS)

Haemorrhagic Fever with Renal Syndrome (HFRS)

By Mode of Transmission:

Urine

Faces

Salvia

Rodent Bite

Airborne Particles Containing These Excretions

By Drug Type:

Branded

Generic

By Route of Administration:

Oral

Injectable

Others

By End Uses:

Hospitals

Academic Research Institutes

Others

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027

Target Audience of the Global Hanta Virus Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Hanta Virus Market, by Region, 2019-2027 (USD Billion)

1.2.2. Hanta Virus Market, by Symptoms, 2019-2027 (USD Billion)

1.2.3. Hanta Virus Market, by Mode of Transmission, 2019-2027 (USD Billion)

1.2.4. Hanta Virus Market, by Drug Type, 2019-2027 (USD Billion)

1.2.5. Hanta Virus Market, by Route of Administration, 2019-2027 (USD Billion)

1.2.6. Hanta Virus Market, by End Uses, 2019-2027 (USD Billion)

1.2.7. Hanta Virus Market, by Distribution Channel, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Hanta Virus Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Hanta Virus Market Dynamics

3.1. Hanta Virus Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Increasing in new cases

3.1.2. Market Challenges

3.1.2.1. Lack of proper medication

3.1.3. Market Opportunities

3.1.3.1. Increasing in awareness about the virus

Chapter 4. Global Hanta Virus Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Hanta Virus Market, by Symptoms

6.1. Market Snapshot

6.2. Global Hanta Virus Market by Symptoms, Performance - Potential Analysis

6.3. Global Hanta Virus Market Estimates & Forecasts by Symptoms 2018-2027 (USD Billion)

6.4. Hanta Virus Market, Sub Segment Analysis

6.4.1. Fever

6.4.2. Body Aches

6.4.3. Hemolytic Anaemia

6.4.4. Thrombocytopenia

6.4.5. Abdominal Pain

6.4.6. Hantavirus Pulmonary Syndrome (HPS)

6.4.7. Haemorrhagic Fever with Renal Syndrome (HFRS)

Chapter 7. Global Hanta Virus Market, by Mode of Transmission

7.1. Market Snapshot

7.2. Global Hanta Virus Market by Mode of Transmission, Performance - Potential Analysis

7.3. Global Hanta Virus Market Estimates & Forecasts by Mode of Transmission 2018-2027 (USD Billion)

7.4. Hanta Virus Market, Sub Segment Analysis

7.4.1. Urine

7.4.2. Faces

7.4.3. Salvia

7.4.4. Rodent Bite

7.4.5. Airborne Particles Containing These Excretions

Chapter 8. Global Hanta Virus Market, by Drug Type

8.1. Market Snapshot

8.2. Global Hanta Virus Market by Drug Type, Performance - Potential Analysis

8.3. Global Hanta Virus Market Estimates & Forecasts by Drug Type2018-2027 (USD Billion)

8.4. Hanta Virus Market, Sub Segment Analysis

8.4.1. Branded

8.4.2. Generic

Chapter 9. Global Hanta Virus Market, by Route of Administration

9.1. Market Snapshot

9.2. Global Hanta Virus Market by Route of Administration, Performance - Potential Analysis

9.3. Global Hanta Virus Market Estimates & Forecasts by Route of Administrations 2018-2027 (USD Billion)

9.4. Hanta Virus Market, Sub Segment Analysis

9.4.1. Oral

9.4.2. Injectable

9.4.3. Others

Chapter 10. Global Hanta Virus Market, by End Uses

10.1. Market Snapshot

10.2. Global Hanta Virus Market by End Uses, Performance - Potential Analysis

10.3. Global Hanta Virus Market Estimates & Forecasts by End Uses 2018-2027 (USD Billion)

10.4. Hanta Virus Market, Sub Segment Analysis

10.4.1. Hospitals

10.4.2. Academic Research Institutes

10.4.3. Others

Chapter 11. Global Hanta Virus Market, by Distribution Channel

11.1. Market Snapshot

11.2. Global Hanta Virus Market by Distribution Channel, Performance - Potential Analysis

11.3. Global Hanta Virus Market Estimates & Forecasts by Distribution Channel 2018-2027 (USD Billion)

11.4. Hanta Virus Market, Sub Segment Analysis

11.4.1. Hospital Pharmacy

11.4.2. Retail Pharmacy

11.4.3. Others

Chapter 12. Global Hanta Virus Market, Regional Analysis

12.1. Hanta Virus Market, Regional Market Snapshot

12.2. North America Hanta Virus Market

12.2.1. U.S. Hanta Virus Market

12.2.1.1. Symptoms breakdown estimates & forecasts, 2018-2027

12.2.1.2. Mode of Transmission breakdown estimates & forecasts, 2018-2027

12.2.1.3. Drug Type breakdown estimates & forecasts, 2018-2027

12.2.1.4. Route of Administration breakdown estimates & forecasts, 2018-2027

12.2.1.5. End Uses breakdown estimates & forecasts, 2018-2027

12.2.1.6. Distribution Channel breakdown estimates & forecasts, 2018-2027

12.2.2. Canada Hanta Virus Market

12.3. Europe Hanta Virus Market Snapshot

12.3.1. U.K. Hanta Virus Market

12.3.2. Germany Hanta Virus Market

12.3.3. France Hanta Virus Market

12.3.4. Spain Hanta Virus Market

12.3.5. Italy Hanta Virus Market

12.3.6. Rest of Europe Hanta Virus Market

12.4. Asia-Pacific Hanta Virus Market Snapshot

12.4.1. China Hanta Virus Market

12.4.2. India Hanta Virus Market

12.4.3. Japan Hanta Virus Market

12.4.4. Australia Hanta Virus Market

12.4.5. South Korea Hanta Virus Market

12.4.6. Rest of Asia Pacific Hanta Virus Market

12.5. Latin America Hanta Virus Market Snapshot

12.5.1. Brazil Hanta Virus Market

12.5.2. Mexico Hanta Virus Market

12.6. Rest of The World Hanta Virus Market

Chapter 13. Competitive Intelligence

13.1. Top Market Strategies

13.2. Company Profiles

13.2.1. PharmJet

13.2.1.1. Key Information

13.2.1.2. Overview

13.2.1.3. Financial (Subject to Data Availability)

13.2.1.4. Product Summary

13.2.1.5. Recent Developments

13.2.2. Taj Pharmaceutical Limited.

13.2.3. Lupin

13.2.4. Merck Sharp & Dohme Corp.

13.2.5. Genentech, Inc.

13.2.6. Aurobindo Pharma

13.2.7. Zydus Pharmaceuticals, Inc.

13.2.8. F. Hoffmann-La Roche Ltd.

13.2.9. Kadmon Pharmaceuticals

13.2.10. Schering Corp

Chapter 14. Research Process

14.1. Research Process

14.1.1. Data Mining

14.1.2. Analysis

14.1.3. Market Estimation

14.1.4. Validation

14.1.5. Publishing

14.2. Research Attributes

14.3. Research Assumption

List of Tables

TABLE 1. Global Hanta Virus market, report scope

TABLE 2. Global Hanta Virus market estimates & forecasts by Region 2018-2027 (USD Billion)

TABLE 3. Global Hanta Virus market estimates & forecasts by Symptoms 2018-2027 (USD Billion)

TABLE 4. Global Hanta Virus market estimates & forecasts by Mode of Transmission 2018-2027 (USD Billion)

TABLE 5. Global Hanta Virus market estimates & forecasts by Drug Type 2018-2027 (USD Billion)

TABLE 6. Global Hanta Virus market estimates & forecasts by Route of Adminstration 2018-2027 (USD Billion)

TABLE 7. Global Hanta Virus market estimates & forecasts by End Uses 2018-2027 (USD Billion)

TABLE 8. Global Hanta Virus market estimates & forecasts by Distribution Channel 2018-2027 (USD Billion)

TABLE 9. Global Hanta Virus market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Hanta Virus market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Hanta Virus market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Hanta Virus market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Hanta Virus market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Hanta Virus market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. Global Hanta Virus market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. Global Hanta Virus market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 17. Global Hanta Virus market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 18. Global Hanta Virus market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 19. U.S. Hanta Virus market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 20. U.S. Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 21. U.S. Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 22. Canada Hanta Virus market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 23. Canada Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 24. Canada Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 25. UK Hanta Virus market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 26. UK Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 27. UK Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 28. Germany Hanta Virus market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 29. Germany Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 30. Germany Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 31. RoE Hanta Virus market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 32. RoE Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 33. RoE Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 34. China Hanta Virus market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 35. China Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 36. China Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 37. India Hanta Virus market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 38. India Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 39. India Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 40. Japan Hanta Virus market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 41. Japan Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 42. Japan Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 43. RoAPAC Hanta Virus market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 44. RoAPAC Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 45. RoAPAC Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 46. Brazil Hanta Virus market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 47. Brazil Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 48. Brazil Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 49. Mexico Hanta Virus market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 50. Mexico Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 51. Mexico Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 52. RoLA Hanta Virus market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 53. RoLA Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 54. RoLA Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 55. Row Hanta Virus market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 56. Row Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 57. Row Hanta Virus market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 58. List of secondary sources, used in the study of global Hanta Virus market

TABLE 59. List of primary sources, used in the study of global Hanta Virus market

TABLE 60. Years considered for the study

TABLE 61. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390